Adiponectin levels are negatively correlated with the risk of type II diabetes and coronary artery disease due to their anti-diabetic, anti-atherosclerotic, and anti-inflammatory effects. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.